Established Ro's leadership in the telehealth weight loss space
ro.co
Ozempic, Zepbound, and other GLP-1 medications are one of the most novel, popular drug categories of this century.
I directly led Product Management efforts for Ro Body, and in collaboration with the tech team, Marketing, Data, Finance, and Ops, established Ro as the go-to option for patients seeking treatment.
We achieved successful outcomes through a series of strategic bets and initiatives, including but not limited to:
+ Creating an in-house metabolic lab testing solution, which included at at-home lab kit product.
+ Establishing a new process around insurance benefits verification and prior authorization to help reduce med costs and increase access to patients.
+ Experimenting and iterating on reducing onboarding friction to help patients get started on medication.
+ Launching new GLP-1 offerings on the platform, including Ro's collaboration with Eli Lilly to offer Zepbound Vials at the lowest price on the market.
